@bombszelberger @LizWebsterSBF It is hellishly difficult to compare ‘drugs shortages’ Study enclosed, quote: A strong link between production and market attractiveness is proposed. So I used more available link. Similar to tomatoes. Problem everywhere bu
@Alichat66 Have been various medicines shortages in the EU members & tbh Worldwide, been widely documented even before 2016 https://t.co/YSWSmkQ7i2 https://t.co/YHJteyCzjL Good overall report https://t.co/60DnIpOgoR
@MrsAitchBee Yes drug shortages are an entirely post Brexit vote phenomena... https://t.co/iSVkkpb9ji
Drug shortages are a global problem. While extensively studied in the United States, numbers about drug shortages in European countries are scarce. https://t.co/DJ6wFuSOaS https://t.co/MbsVTV75yq
@theveindoc @jim_crawfurd Been happening for many years all over the EU, read a few papers on it a while back, have link to this one https://t.co/YHJteyCzjL but newer ones are online from. Denmark and Holland, likely many others too.
@albion2016 @jlofromtarn @Alichat66 @Beloved_Black_C @_Loggerheads Logged into NCBI/NIH and research paper free it seems, data from 2005+<=2013 interesting as shortages underreported but major cause seems to be manufacturing issues https://t.co/YHJteyCz
Let's have a Canadian-made #pharmacare plan. Drug shortages in European countries: a trade-off between market attractiveness and cost containment? - PubMed - NCBI https://t.co/diGeWOtHfO
Reporting of drug #shortages in Europe needs to be standardized and more transparency is required https://t.co/tQpaWteunf #bmchealthservres
Drug shortages in European countries:a trade-off between market attractiveness and cost containment? @DArpinoDarpino http://t.co/cxySsqlVOZ
Drug shortages in European countries:a trade-off between market attractiveness and cost containment? @DArpinoDarpino http://t.co/cxySsqlVOZ
Drug shortages in European countries:a trade-off between market attractiveness and cost containment? @DArpinoDarpino http://t.co/cxySsqlVOZ
Drug shortages in European countries:a trade-off between market attractiveness and cost containment? @DArpinoDarpino http://t.co/cxySsqlVOZ
#Drugshortages in European countries: a trade-off between market attractiveness and cost containment?http://t.co/KX9p8SHVDP
#Drugshortages in European countries: a trade-off between market attractiveness and cost containment?http://t.co/KX9p8SHVDP
Drug Shortages in EU - Trade-Off → Market Attractiveness & Cost Containment? http://t.co/9xPNEouY59 http://t.co/87xa1NufLy HT @LeuvenU
Drug Shortages in EU - Trade-Off → Market Attractiveness & Cost Containment? http://t.co/9Qn32qmU4W http://t.co/CPr6Q0SIbN HT @LeuvenU
Drug Shortages in EU - Trade-Off → Market Attractiveness & Cost Containment? http://t.co/9Qn32qmU4W http://t.co/CPr6Q0SIbN HT @LeuvenU
Drug Shortages in EU - Trade-Off → Market Attractiveness & Cost Containment? http://t.co/9xPNEouY59 http://t.co/87xa1NufLy HT @LeuvenU
Drug Shortages in EU - Trade-Off → Market Attractiveness & Cost Containment? http://t.co/9Qn32qmU4W http://t.co/CPr6Q0SIbN HT @LeuvenU
Drug Shortages in EU - Trade-Off → Market Attractiveness & Cost Containment? http://t.co/9Qn32qmU4W http://t.co/CPr6Q0SIbN HT @LeuvenU